- NEWS EXPLAINER
More Alzheimer’s drugs head for FDA review: what scientists are watching
Access options
Nature 599, 544-545 (2021)
doi: https://doi.org/10.1038/d41586-021-03410-9
References
Mintun, M. A. et al. N. Engl. J. Med. 384, 1691–1704 (2021).
Emanuel, E. J. JAMA 326, 1367–1368 (2021).
Dunn, B., Stein, P. & Cavazzoni, P. JAMA Intern Med. 181, 1276–1278 (2021).
Dunn, B., Stein, P., Temple, R. & Cavazzoni, P. N. Engl. J. Med. 385, 856–857 (2021).